AMANDA OSEI: Open Payments
NPI 1235738006 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,357 in 175 payments from 20 companies in 2025. Trend: 2023 $1,170 · 2024 $3,848 · 2025 $3,357
Food & beverage: $3,357
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $825 |
| Madrigal Pharmaceuticals | 16 | $310 |
| Ardelyx, Inc. | 14 | $300 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $232 |
| PFIZER INC. | 11 | $199 |
| Phathom Pharmaceuticals, Inc. | 17 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $187 |
| GENZYME CORPORATION | 10 | $179 |
| Janssen Biotech, Inc. | 7 | $162 |
| QOL Medical, LLC | 6 | $135 |
Products named: RINVOQ, REZDIFFRA, IBSRELA, DUPIXENT, XIFAXAN, VOQUEZNA, TREMFYA, Sucraid.
Industry payments across VA — which companies pay providers there.
